We Can Help

The costs of mesothelioma can be overwhelming. They can include income loss, expensive treatments that may not be covered by health insurance, plus pain and suffering for you and for your family. Because the disease is preventable – and because it is usually caused by someone else’s negligence – legal options may be available to help regain these costs. Asbestos lawyers focus their practice on knowledgeably and effectively bringing to justice companies that exposed employees and the public to asbestos products. A mesothelioma attorney can help you consider your options and file a claim against the company responsible for your asbestos-related illness. More than one company may be responsible. A mesothelioma attorney identifies all companies at fault. Mesothelioma lawsuits have helped thousands of people receive financial assistance. A lawsuit can result in much-needed money to help reduce financial hardships during an illness and can also provide a more stable future for your loved ones. A lawyer specializing in asbestos litigation can help you seek compensation for expenses related to illness caused by asbestos exposure.

Study Shows Opdivo, Yervoy Effective After Mesothelioma Surgery

Patients with recurrent mesothelioma cancer often have few options. A new study by the Hyogo College of Medicine in Japan may have a potential answer. This study tested the safety and efficacy of two drugs following mesothelioma surgery after cancer recurrence. The combination of immunotherapy drugs nivolumab and ipilimumab, known by the brand names Opdivo […]

The post Study Shows Opdivo, Yervoy Effective After Mesothelioma Surgery appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Mesothelioma Surgery With Immunotherapy Proves Effective in Study

An immunotherapy combination given before aggressive surgery has shown impressive effectiveness in extending survival for pleural mesothelioma patients in a recent phase II clinical trial at Baylor College of Medicine. The combination of immune checkpoint inhibitors durvalumab and tremelimumab showed an ability to effectively alter the intratumoral immune system and make surgery more effective. This […]

The post Mesothelioma Surgery With Immunotherapy Proves Effective in Study appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

New Research Focuses on Mesothelioma Brain Metastasis

Distant metastasis is common with malignant pleural mesothelioma – more than 60% of patients experience it – but rarely is it found around the brain. A new study by a team of radiation oncologists in Great Britain, however, suggests that physicians should increase their focus on potential cerebral metastasis in mesothelioma patients. “Patients will continue […]

The post New Research Focuses on Mesothelioma Brain Metastasis appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Blood Serum Diagnostic Test for Mesothelioma Explored in Study

One of the biggest obstacles to treating pleural mesothelioma cancer effectively is its often late-stage diagnosis. A recent study shows encouraging signs that those days could be ending. Novel diagnostic testing using blood serum and infrared spectroscopy is being explored to better characterize and differentiate mesothelioma in its early stages from other lung diseases and […]

The post Blood Serum Diagnostic Test for Mesothelioma Explored in Study appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Mesothelioma Clinical Trial Studies Keytruda, Lenvatinib Combination

A possible second-line treatment for pleural mesothelioma may be on the horizon after a phase II clinical trial showed impressive efficacy with early returns from the Netherlands Cancer Institute in Amsterdam. The single-arm, open-label clinical trial involved the combination of pembrolizumab, an immunotherapy drug known by the brand name Keytruda, in combination with lenvatinib. Synergy […]

The post Mesothelioma Clinical Trial Studies Keytruda, Lenvatinib Combination appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

MARF to Host International Symposium on Malignant Mesothelioma

Leading medical specialists will gather with mesothelioma patients, families, friends and advocates at the much-anticipated 2022 International Symposium on Malignant Mesothelioma, July 23, in Chicago. This is an event well worth attending. The day-long symposium will be held at Summit Chicago, a welcoming venue where a wide range of mesothelioma experts will be speaking on […]

The post MARF to Host International Symposium on Malignant Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Researchers in Japan Study Inhalable Gene Therapy for Mesothelioma

Patients with malignant pleural mesothelioma may be turning to orally inhalable gene therapy in the future, easing the treatment burden for this cancer with no cure. The recent focus on identifying genetic mutations that make individuals more susceptible to certain cancers – including mesothelioma – has led to related research on how best to combat […]

The post Researchers in Japan Study Inhalable Gene Therapy for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]

Heated Intrathoracic Chemotherapy Could Extend Mesothelioma Survival

Patients with pleural mesothelioma undergoing aggressive surgery should consider combining it with controversial hyperthermic intrathoracic chemotherapy to extend survival, according to a recent study. Although the procedure, also known as HITHOC, has yet to be proven effective in a randomized clinical trial – and still is being debated by mesothelioma specialists – the report has […]

The post Heated Intrathoracic Chemotherapy Could Extend Mesothelioma Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

[…]